# K093005: Fora G72 Blodo Glucose Monitoring System/TD-4264 Blood Glucose Monitoring System, Model TD-4264

- Pathway: 510(k) (Special)
- Applicant: Taidoc Technology Corporation
- Decided: Feb 5, 2010 after 130 days
- Product code: NBW (System, Test, Blood Glucose, Over The Counter)
- Device class: 2
- Regulation: 21 CFR 862.1345
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K090185 (2009). 1 ancestor in all.
No later device cites it as a predicate yet.
0 of 2 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K090185: Clever Chek Blood Glucose Monitoring System; Achtung Blood Glucose Monitoring System, Taidoc Technology Corporation (2009) Summary page 1.

## Indications for use
The FORA G72 / TD-4264 Blood Glucose Monitoring System, FORA G70 / TD-4273 Blood Glucose Monitoring System, and Ultra Trak Active Blood Glucose Monitoring System are intended for use in the quantitative measurement of glucose in fresh capillary whole blood samples from the finger and the following alternative sites: the palm, the forearm, the upper-arm, the calf and the thigh. They are intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of diabetes control program. They are not intended for the diagnosis of or screening for diabetes mellitus, nor for use on neonates. The alternative site testing in above systems can be used only during steady-state blood glucose conditions.

Source page: https://510kreport.com/device/K093005
Methodology: https://510kreport.com/methodology